2
Registered trials
2
Recruiting
2
Unique sponsors
3
Unique IMPs
2
Commercial trials
Drug classes (ATC)
—
ATC code not specified
1
S
Ophthalmology/ENT (ATC S)
1
Mechanism of action (INN-stem analysis)
Unknown / small molecule
2 substances
Erythropoietin analogue
1 substance
Phase III:
1
Phase II:
1
Phase III
1 trial-
RecruitingDompe' Farmaceutici S.p.A. CommercialCENEGERMIN; OXYBUPROCAINE HYDROCHLORIDE, TETRACAINE HYDROCHLORIDE
Phase II
1 trial-
RecruitingGlaukos Corp. CommercialLUFEPIRSEN
Sponsor activity
| Sponsor | Type | Trials | Phases | Recruiting |
|---|---|---|---|---|
| Glaukos Corp. | Commercial | 1 | Phase II | 1 |
| Dompe' Farmaceutici S.p.A. | Commercial | 1 | Phase III | 1 |
New trials by year
2025
1
2026
1